These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 8781139)

  • 1. Uptake of iodine-123-alpha-methyl tyrosine by gliomas and non-neoplastic brain lesions.
    Kuwert T; Morgenroth C; Woesler B; Matheja P; Palkovic S; Vollet B; Samnick S; Maasjosthusmann U; Lerch H; Gildehaus FJ; Wassmann H; Schober O
    Eur J Nucl Med; 1996 Oct; 23(10):1345-53. PubMed ID: 8781139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-invasive grading of primary brain tumours: results of a comparative study between SPET with 123I-alpha-methyl tyrosine and PET with 18F-deoxyglucose.
    Woesler B; Kuwert T; Morgenroth C; Matheja P; Palkovic S; Schäfers M; Vollet B; Schäfers K; Lerch H; Brandau W; Samnick S; Wassmann H; Schober O
    Eur J Nucl Med; 1997 Apr; 24(4):428-34. PubMed ID: 9096095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 3-[123I]Iodo-alpha-methyl-L-tyrosine uptake in cerebral gliomas: relationship to histological grading and prognosis.
    Schmidt D; Gottwald U; Langen KJ; Weber F; Hertel A; Floeth F; Felsberg J; Reifenberger G; Coenen HH; Müller-Gärtner HW
    Eur J Nucl Med; 2001 Jul; 28(7):855-61. PubMed ID: 11504082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of l-3-[123I]iodo-alpha-methyltyrosine SPET and [18F]fluorodeoxyglucose PET in the detection and grading of recurrences in patients pretreated for gliomas at follow-up: a comparative study with stereotactic biopsy.
    Bader JB; Samnick S; Moringlane JR; Feiden W; Schaefer A; Kremp S; Kirsch CM
    Eur J Nucl Med; 1999 Feb; 26(2):144-51. PubMed ID: 9933348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sequential scintigraphic strategy for the differentiation of brain tumours.
    Matheja P; Rickert C; Weckesser M; Palkovic S; Löttgen J; Riemann B; Kopka K; Kuwert T; Wassmann H; Paulus W; Schober O
    Eur J Nucl Med; 2000 May; 27(5):550-8. PubMed ID: 10853811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical value of iodine-123-alpha-methyl-L-tyrosine single-photon emission tomography in the differential diagnosis of recurrent brain tumor in patients pretreated for glioma at follow-up.
    Samnick S; Bader JB; Hellwig D; Moringlane JR; Alexander C; Romeike BF; Feiden W; Kirsch CM
    J Clin Oncol; 2002 Jan; 20(2):396-404. PubMed ID: 11786566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of size of regions of interest on the measurement of uptake of 123I-alpha-methyl tyrosine by brain tumours.
    Kuwert T; Morgenroth C; Woesler B; Matheja P; Palkovic S; Vollet B; Schäfers M; Wassmann H; Schober O
    Nucl Med Commun; 1996 Jul; 17(7):609-15. PubMed ID: 8843121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis of recurrent glioma with SPECT and iodine-123-alpha-methyl tyrosine.
    Kuwert T; Woesler B; Morgenroth C; Lerch H; Schäfers M; Palkovic S; Matheja P; Brandau W; Wassmann H; Schober O
    J Nucl Med; 1998 Jan; 39(1):23-7. PubMed ID: 9443732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intra-individual comparison of p-[123I]-iodo-L-phenylalanine and L-3-[123I]-iodo-alpha-methyl-tyrosine for SPECT imaging of gliomas.
    Hellwig D; Romeike BF; Ketter R; Moringlane JR; Kirsch CM; Samnick S
    Eur J Nucl Med Mol Imaging; 2008 Jan; 35(1):24-31. PubMed ID: 17846769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Iodine-123 alpha-methyl tyrosine single-photon emission tomography of cerebral gliomas: standardised evaluation of tumour uptake and extent.
    Weckesser M; Griessmeier M; Schmidt D; Sonnenberg F; Ziemons K; Kemna L; Holschbach M; Langen K; Müller-Gärtner H
    Eur J Nucl Med; 1998 Feb; 25(2):150-6. PubMed ID: 9473263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Iodine-123-alpha-methyl tyrosine in gliomas: correlation with cellular density and proliferative activity.
    Kuwert T; Probst-Cousin S; Woesler B; Morgenroth C; Lerch H; Matheja P; Palkovic S; Schäfers M; Wassmann H; Gullotta F; Schober O
    J Nucl Med; 1997 Oct; 38(10):1551-5. PubMed ID: 9379191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of clinical usefulness of 131I alpha-methyl-tyrosine and fused SPECT/MRI imaging for diagnostics of recurrent cerebral gliomas.
    Górska-Chrzastek M; Grzelak P; Bieńkiewicz M; Tybor K; Zakrzewska E; Mikołajczak R; Stefańczyk L; Kuśmierek J
    Nucl Med Rev Cent East Eur; 2004; 7(2):135-41. PubMed ID: 15968600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 3-[123I]iodo-alpha-methyltyrosine and [methyl-11C]-L-methionine uptake in cerebral gliomas: a comparative study using SPECT and PET.
    Langen KJ; Ziemons K; Kiwit JC; Herzog H; Kuwert T; Bock WJ; Stöcklin G; Feinendegen LE; Müller-Gärtner HW
    J Nucl Med; 1997 Apr; 38(4):517-22. PubMed ID: 9098193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigation of iodine-123-labelled amino acid derivatives for imaging cerebral gliomas: uptake in human glioma cells and evaluation in stereotactically implanted C6 glioma rats.
    Samnick S; Richter S; Romeike BF; Heimann A; Feiden W; Kempski O; Kirsch CM
    Eur J Nucl Med; 2000 Oct; 27(10):1543-51. PubMed ID: 11083545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The role of L-3-I-123-iodine-alpha-methyltyrosine SPECT in cerebral gliomas].
    Weckesser M; Schmidt D; Matheja P; Coenen HH; Langen KJ
    Nuklearmedizin; 2000 Dec; 39(8):233-40. PubMed ID: 11189900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implications of IMT-SPECT for postoperative radiotherapy planning in patients with gliomas.
    Grosu AL; Feldmann H; Dick S; Dzewas B; Nieder C; Gumprecht H; Frank A; Schwaiger M; Molls M; Weber WA
    Int J Radiat Oncol Biol Phys; 2002 Nov; 54(3):842-54. PubMed ID: 12377338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Value of 123I-IMT SPECT for diagnosis of recurrent non-astrocytic intracranial tumours.
    Plotkin M; Amthauer H; Eisenacher J; Wurm R; Michel R; Wust P; Stockhammer F; Röttgen R; Gutberlet M; Ruf J; Felix R
    Neuroradiology; 2005 Jan; 47(1):18-26. PubMed ID: 15630586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of tumour progression in the follow-up of irradiated low-grade astrocytomas: comparison of 3-[123I]iodo-alpha-methyl- L-tyrosine and 99mTc-MIBI SPET.
    Henze M; Mohammed A; Schlemmer H; Herfarth KK; Mier W; Eisenhut M; Debus J; Haberkorn U
    Eur J Nucl Med Mol Imaging; 2002 Nov; 29(11):1455-61. PubMed ID: 12397464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. First experience with I-123-alpha-methyl-tyrosine spect in the 3-D radiation treatment planning of brain gliomas.
    Grosu AL; Weber W; Feldmann HJ; Wuttke B; Bartenstein P; Gross MW; Lumenta C; Schwaiger M; Molls M
    Int J Radiat Oncol Biol Phys; 2000 May; 47(2):517-26. PubMed ID: 10802381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluorine-18-FDG PET and iodine-123-IMT SPECT in the evaluation of brain tumors.
    Weber W; Bartenstein P; Gross MW; Kinzel D; Daschner H; Feldmann HJ; Reidel G; Ziegler SI; Lumenta C; Molls M; Schwaiger M
    J Nucl Med; 1997 May; 38(5):802-8. PubMed ID: 9170450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.